[1]
|
Kito, M., et al. (2002) Construction of engineered CHO strains for high-level production of recombinant proteins. Applied Microbiological Biotechnology, 60, 442-448.
doi:10.1007/s00253-002-1134-1
|
[2]
|
Barnes, L.M., Bentley, C.M. and Dickson, A.J. (2000) Advances in animal cell recombinant protein production: GS-NS0 expression system. Cy-totechnology, 32, 109123. doi:10.1023/A:1008170710003
|
[3]
|
Farid, S.S. (2006) Established bioprocesses for producing antibodies as a basis for future planning. Advances in Biochemical Engineering/Biotechnology, 101, 1-42.
doi:10.1007/10_014
|
[4]
|
Cregg, J.M., et al. (2000) Recombinant protein expression in Pichia pastoris. Molecular Biotechnology, 16, 2352. doi:10.1385/MB:16:1:23
|
[5]
|
Romanos, M.A., Scorer, C.A. and Clare, J.J. (1992) Foreign gene expression in yeast: A review. Yeast, 8, 423488. doi:10.1002/yea.320080602
|
[6]
|
Cregg, J.M., et al. (1985) Pichia pastoris as a host system for transformations. Molecular Cell Biology, 5, 33763385.
|
[7]
|
Grinna, L.S. and Tschopp, J.F. (1989) Size distribution and general structural features of N-linked oli-gosaccharides from the methylotrophic yeast, Pichia pastoris. Yeast, 5, 107-115. doi:10.1002/yea.320050206
|
[8]
|
Goodrick, J.C., et al. (2001) High-level expression and stabilization of recombinant human chitinase produced in a continuous constitutive Pichia pastoris expression system. Biotechnology and Bioengineering, 74, 492-497.
doi:10.1002/bit.1140
|
[9]
|
Schilling, B.M., Goodrick, J.C. and Wan, N.C. (2001) Scale-up of a high cell density continuous culture with Pichia pastoris X-33 for the con-stitutive expression of rhchitinase. Biotechnology Progress, 17, 629-633.
doi:10.1021/bp010041e
|
[10]
|
Hellwig, S., et al. (2001) Analysis of single-chain antibody production in Pichia pastoris using online methanol control in fed-batch and mixed-feed fermentations. Biotechnology and bioengineering, 74, 344-352.
doi:10.1002/bit.1125
|
[11]
|
Carter, P., et al. (1992) Humanization of an anti-p185HER2 antibody for human cancer therapy. Proceedings of National Academy Science of the USA, 89, 4285-4289.
doi:10.1073/pnas.89.10.4285
|
[12]
|
Shibui, T. and Nagahari, K. (1992) Secretion of a functional Fab fragment in Escherichia coli and the influence of culture conditions. Applied Microbiological Biotechnology, 37, 352-357. doi:10.1007/BF00210991
|
[13]
|
Cabilly, S. (1989) Growth at sub-optimal temperatures allows the production of functional, anti-gen-binding Fab fragments in Escherichia coli. Gene, 85, 553-557.
doi:10.1016/0378-1119(89)90451-4
|
[14]
|
Dean, N. (1999) Asparagine-linked glycosylation in the yeast Golgi. Biochimica et Biophysica Acta, 1426, 309322. doi:10.1016/S0304-4165(98)00132-9
|
[15]
|
Ballou, C.E. (1990) Isolation, characterization, and properties of Saccharomyces cerevisiae mnn mutants with nonconditional protein glycosylation defects. Methods Enzymology, 185, 440-470.
doi:10.1016/0076-6879(90)85038-P
|
[16]
|
Yip, C.L., et al. (1994) Cloning and analysis of the Saccharomyces cerevisiae MNN9 and MNN1 genes required for complex glycosylation of secreted proteins. Proceedings of National Academy Science of the USA, 91, 27232727. doi:10.1073/pnas.91.7.2723
|
[17]
|
Niwa, R., et al. (2004) Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma. Cancer Research, 64, 2127-2133. doi:10.1158/0008-5472.CAN-03-2068
|
[18]
|
Yamane-Ohnuki, N., et al. (2004) Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnology and bioengineering, 87, 614-622.
doi:10.1002/bit.20151
|